Today's Date: November 27, 2021
Treasury Board of Canada President, Mona Fortier, tables the Supplementary Estimates (B) 2021-22   •   Mary Kay Inc. and the Mary Kay Ash Foundation Further Commit to the Prevention and Elimination of Global Gender-Based Violence   •   Native Americans - Absent in Higher Education   •   Torrid Announces Reporting Date for Third Quarter Fiscal 2021 Financial Results   •   Canada Post makes mail and parcel delivery more accessible to all customers   •   Economic growth in Quebec's Indigenous communities--The Government of Canada announces the renewal of the True North Treasure an   •   Academy Awards® Accredited Short Shorts Film Festival & Asia presents Japan Cultural Expo Project: Creation of Stories A   •   Integrity Announces Donation of $100,000 to Purchase Toys for Children's Health to Comfort Young Patients   •   Capstone CEO To Report on Smart Mirror Launch   •   Walmart To Participate in Both the Stephens Investment Conference and the Morgan Stanley Virtual Global Consumer & Retail Co   •   Flora Growth Forms JV With Avaria Health and Beauty to Distribute Award-Winning Pain Products Across LATAM   •   spermidineLIFE® Immunity+ and spermidineLIFE® Memory+ Launch in U.S.   •   Prime Minister and Premier of British Columbia announce new committee to address extreme weather and climate resilience in the p   •   Rainer Hughes kicks off with its initiative: Little Steps To nurture the stars of tomorrow   •   Online store pauses sales during busiest buying days, encourages shoppers to send 5,000 care packages to children   •   Statement from the Chief Public Health Officer of Canada - Importance of COVID-19 Vaccination in Pregnant, Recently Pregnant and   •   Establishment Labs Announces Participation in the Stephens Annual Investment Conference   •   Affordable ZTE Blade A7P Android Smartphone Arrives for the Holidays   •   Is Your Thanksgiving Stuffing Contaminated With Toxic Lead?   •   Guess?, Inc. Announces Participation at the Morgan Stanley Virtual Global Consumer & Retail Conference
Bookmark and Share

Establishment Labs Announces Participation in the Stephens Annual Investment Conference

SANTA BARBARA, Calif. , November 24 /Businesswire/ - Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Interim Chief Financial Officer and Head of Strategy and Investor Relations, will participate in the Stephens Annual Investment Conference, which is being held December 1-3, 2021. Mr. Chacón-Quirós and Mr. Denhoy are scheduled to speak in-person to conference attendees at 1:00 pm CT on Thursday, December 2, 2021.

A live webcast of the presentation will be available to all interested parties on the Establishment Labs investor relations website at https://investors.establishmentlabs.com/. An archived version of the webcast will be available on the same website following the completion of the event.

About Establishment Labs

Establishment Labs Holdings Inc. is a global medical technology company dedicated to improving women’s health and wellness. The company’s initial focus is breast health, principally breast aesthetics and reconstruction. Establishment Labs offers a portfolio of advanced silicone gel-filled breast implants, branded as Motiva Implants® that include a number of innovative and patented features designed to deliver improved aesthetic and clinical outcomes. Since commercial launch in 2010, more than 1.8 million Motiva Implants® have been delivered to plastic surgeons in over 80 countries. The company also offers or has under development a number of related products and technologies, including the Motiva Flora® tissue expander and Motiva MIA®, the company’s minimally invasive breast enhancement procedure. In 2018, Establishment Labs received an investigational device exemption (IDE) from the FDA for the Motiva Implant® and began a clinical trial to support regulatory approval in the United States. Motiva Implants® are manufactured at the company’s two facilities in Costa Rica, which are compliant with all applicable regulatory standards under ISO13485:2016 and FDA 21 CFR 820 under the MDSAP program. Please visit our website for additional information at www.establishmentlabs.com.


STORY TAGS: Medical Supplies, Health, Medical Devices, Consumer, Women, Surgery, General Health, California, Conference, Webcast, United States, North America,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News